Free Trial

Profound Medical Q3 2024 Earnings Report

Profound Medical logo
$5.02 -0.35 (-6.54%)
As of 02:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Profound Medical EPS Results

Actual EPS
-$0.38
Consensus EPS
-$0.33
Beat/Miss
Missed by -$0.05
One Year Ago EPS
-$0.26

Profound Medical Revenue Results

Actual Revenue
$2.83 million
Expected Revenue
$3.30 million
Beat/Miss
Missed by -$470.00 thousand
YoY Revenue Growth
N/A

Profound Medical Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Remove Ads

Profound Medical Earnings Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Profound Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Profound Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Profound Medical and other key companies, straight to your email.

About Profound Medical

Profound Medical (NASDAQ:PROF), together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

View Profound Medical Profile

More Earnings Resources from MarketBeat